HER2 Lung Cancer Epidemiology Forecast | HER2 Lung Cancer Prevalent Population

1. Key Insights

2. Executive Summary of HER2 Lung Cancer

3. HER2 Lung Cancer: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. HER2 Lung Cancer Epidemiology Scenario in the 7MM (2021-2034)

5.4. United States Epidemiology

5.4.1. HER2 Lung Cancer Epidemiology Scenario in the United States (2021-2034)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. HER2 Lung Cancer Epidemiology Scenario in Germany (2021-2034)

5.5.2. France Epidemiology

5.5.2.1. HER2 Lung Cancer Epidemiology Scenario in France (2021-2034)

5.5.3. Italy Epidemiology

5.5.3.1. HER2 Lung Cancer Epidemiology Scenario in Italy (2021-2034)

5.5.4. Spain Epidemiology

5.5.4.1. HER2 Lung Cancer Epidemiology Scenario in Spain (2021-2034)

5.5.5. United Kingdom Epidemiology

5.5.5.1. HER2 Lung Cancer Epidemiology Scenario in the United Kingdom (2021-2034)

5.6. Japan Epidemiology

5.6.1. HER2 Lung Cancer Epidemiology Scenario in Japan (2021-2034)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. HER2 Lung Cancer Treatment and Management

6.2. HER2 Lung Cancer Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

List of Tables:

Table 1: HER2 Lung Cancer Epidemiology in 7MM (2021-2034)
Table 2: HER2 Lung Cancer Diagnosed and Treatable Cases in 7MM (2021-2034)
Table 3: HER2 Lung Cancer Epidemiology in the United States (2021-2034)
Table 4: HER2 Lung Cancer Diagnosed and Treatable Cases in the United States (2021-2034)
Table 5: HER2 Lung Cancer Epidemiology in Germany (2021-2034)
Table 6: HER2 Lung Cancer Diagnosed and Treatable Cases in Germany (2021-2034)
Table 7: HER2 Lung Cancer Epidemiology in France (2021-2034)
Table 8: HER2 Lung Cancer Diagnosed and Treatable Cases in France (2021-2034)
Table 9: HER2 Lung Cancer Epidemiology in Italy (2021-2034)
Table 10: HER2 Lung Cancer Diagnosed and Treatable Cases in Italy (2021-2034)
Table 11: HER2 Lung Cancer Epidemiology in Spain (2021-2034)
Table 12: HER2 Lung Cancer Diagnosed and Treatable Cases in Spain (2021-2034)
Table 13: HER2 Lung Cancer Epidemiology in the United Kingdom (2021-2034)
Table 14: HER2 Lung Cancer Diagnosed and Treatable Cases in the United Kingdom (2021-2034)
Table 15: HER2 Lung Cancer Epidemiology in Japan (2021-2034)
Table 16: HER2 Lung Cancer Diagnosed and Treatable Cases in Japan (2021-2034)

List of Figures:

Figure 1 HER2 Lung Cancer Epidemiology in 7MM (2021-2034)
Figure 2 HER2 Lung Cancer Diagnosed and Treatable Cases in 7MM (2021-2034)
Figure 3 HER2 Lung Cancer Epidemiology in the United States (2021-2034)
Figure 4 HER2 Lung Cancer Diagnosed and Treatable Cases in the United States (2021-2034)
Figure 5 HER2 Lung Cancer Epidemiology in Germany (2021-2034)
Figure 6 HER2 Lung Cancer Diagnosed and Treatable Cases in Germany (2021-2034)
Figure 7 HER2 Lung Cancer Epidemiology in France (2021-2034)
Figure 8 HER2 Lung Cancer Diagnosed and Treatable Cases in France (2021-2034)
Figure 9 HER2 Lung Cancer Epidemiology in Italy (2021-2034)
Figure 10 HER2 Lung Cancer Diagnosed and Treatable Cases in Italy (2021-2034)
Figure 11 HER2 Lung Cancer Epidemiology in Spain (2021-2034)
Figure 12 HER2 Lung Cancer Diagnosed and Treatable Cases in Spain (2021-2034)
Figure 13 HER2 Lung Cancer Epidemiology in the United Kingdom (2021-2034)
Figure 14 HER2 Lung Cancer Diagnosed and Treatable Cases in the United Kingdom (2021-2034)
Figure 15 HER2 Lung Cancer Epidemiology in Japan (2021-2034)
Figure 16 HER2 Lung Cancer Diagnosed and Treatable Cases in Japan (2021-2034)
*The table of contents is not exhaustive; will be provided in the final report

her2 lung cancer epidemiology forecast Sample Page

Customize Reports As Per Your Needs

ESMO Conference 2024

Have a Question?